Clinical Characteristics and Outcome of Methamphetamine-Associated Pulmonary Arterial Hypertension and Dilated Cardiomyopathy
- PMID: 29496022
- DOI: 10.1016/j.jchf.2017.10.006
Clinical Characteristics and Outcome of Methamphetamine-Associated Pulmonary Arterial Hypertension and Dilated Cardiomyopathy
Abstract
Objectives: This study sought to characterize patients with methamphetamine-associated pulmonary arterial hypertension (MA-PAH) and cardiomyopathy (MA-CMP), to compare with MA controls (MA-CTL), users with structurally normal hearts, with the aim of identifying risk factors for these conditions.
Background: MA-PAH and MA-CMP are 2 poorly understood cardiac complications in MA users.
Methods: We retrospectively studied the clinical characteristics and outcomes of 50 MA-PAH, 296 MA-CMP, and 356 MA-CTL patients, whom we evaluated between 2010 and 2017.
Results: After a median follow-up of 20.0 months (interquartile range [IQR]: 7.6 to 42.6 months), all-cause mortality was 18.0% for MA-PAH, 15.2% for MA-CMP, and 4.5% for MA-CTL group (p < 0.001). More women (58%) were in the MA-PAH group than in the MA-CMP (14%; p < 0.001) and MA-CTL (42%; p = 0.028) groups, whereas the MA-CMP group was predominantly male (86% vs. 58% in the MA-CTL group; p < 0.001). More MA-CMP patients had hypertension (p < 0.001) or alcoholism (p < 0.001) than MA-CTL patients. Logistic regression analyses identified male sex, alcoholism, and hypertension as independent factors associated with MA-CMP with the following respective adjusted odds ratios (OR) of 3.791 (95% confidence interval [CI]: 2.508 to 5.730), OR of 2.959 (95% CI: 2.084 to 4.203), and OR of 2.111 (95% CI: 1.486 to 2.999), whereas female sex was the only factor associated with MA-PAH.
Conclusions: Both MA-PAH and MA-CMP patients carried significant disease burden and mortality risk. Male sex, hypertension, and alcoholism were strongly associated with MA-CMP, whereas female sex and other unknown factors may influence development of MA-PAH. This study adds to the understanding of MA-associated cardiac complications and highlights directions for future investigation.
Keywords: dilated cardiomyopathy; heart failure; methamphetamine; pulmonary arterial hypertension.
Published by Elsevier Inc.
Comment in
-
Crystal Methamphetamine: A Drug and Cardiovascular Epidemic.JACC Heart Fail. 2018 Mar;6(3):219-221. doi: 10.1016/j.jchf.2018.01.004. JACC Heart Fail. 2018. PMID: 29496023 No abstract available.
Similar articles
-
Features and Outcomes of Methamphetamine-associated Pulmonary Arterial Hypertension.Am J Respir Crit Care Med. 2018 Mar 15;197(6):788-800. doi: 10.1164/rccm.201705-0943OC. Am J Respir Crit Care Med. 2018. PMID: 28934596 Free PMC article.
-
Overview of Methamphetamine-Associated Pulmonary Arterial Hypertension.Chest. 2024 Jun;165(6):1518-1533. doi: 10.1016/j.chest.2024.01.014. Epub 2024 Jan 9. Chest. 2024. PMID: 38211700 Review.
-
Polymorphisms in CYP2D6 may predict methamphetamine related heart failure.Clin Toxicol (Phila). 2013 Aug;51(7):540-4. doi: 10.3109/15563650.2013.818684. Epub 2013 Jul 15. Clin Toxicol (Phila). 2013. PMID: 23855716
-
Is methamphetamine use associated with idiopathic pulmonary arterial hypertension?Chest. 2006 Dec;130(6):1657-63. doi: 10.1378/chest.130.6.1657. Chest. 2006. PMID: 17166979
-
Methamphetamine-Associated Cardiomyopathy: Addressing the Clinical Challenges.Heart Lung Circ. 2022 May;31(5):616-622. doi: 10.1016/j.hlc.2021.12.015. Epub 2022 Feb 10. Heart Lung Circ. 2022. PMID: 35153149 Review.
Cited by
-
Is Methadone Safe for Patients With Opioid Use Disorder and Coronavirus Disease 2019 Infection?J Addict Nurs. 2022 Apr-Jun 01;33(2):86-94. doi: 10.1097/JAN.0000000000000457. J Addict Nurs. 2022. PMID: 35640212 Free PMC article.
-
Investigating the "sex paradox" in pulmonary arterial hypertension: Results from the Pulmonary Hypertension Association Registry (PHAR).J Heart Lung Transplant. 2024 Jun;43(6):901-910. doi: 10.1016/j.healun.2024.02.004. Epub 2024 Feb 13. J Heart Lung Transplant. 2024. PMID: 38360160 Free PMC article.
-
Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry.Ann Am Thorac Soc. 2021 Apr;18(4):613-622. doi: 10.1513/AnnalsATS.202007-774OC. Ann Am Thorac Soc. 2021. PMID: 33064950 Free PMC article.
-
Methamphetamine Use and Cardiovascular Disease.Arterioscler Thromb Vasc Biol. 2019 Sep;39(9):1739-1746. doi: 10.1161/ATVBAHA.119.312461. Epub 2019 Aug 21. Arterioscler Thromb Vasc Biol. 2019. PMID: 31433698 Free PMC article. Review.
-
Clinical Correlates and Outcomes of Methamphetamine-Associated Cardiovascular Diseases in Hospitalized Patients in California.J Am Heart Assoc. 2022 Aug 16;11(16):e023663. doi: 10.1161/JAHA.121.023663. Epub 2022 Aug 1. J Am Heart Assoc. 2022. PMID: 35912709 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical